MD223Z - Method for revaccination of children against viral hepatitis B - Google Patents

Method for revaccination of children against viral hepatitis B Download PDF

Info

Publication number
MD223Z
MD223Z MDS20100040A MDS20100040A MD223Z MD 223 Z MD223 Z MD 223Z MD S20100040 A MDS20100040 A MD S20100040A MD S20100040 A MDS20100040 A MD S20100040A MD 223 Z MD223 Z MD 223Z
Authority
MD
Moldova
Prior art keywords
viral hepatitis
against viral
revaccination
hbs
level
Prior art date
Application number
MDS20100040A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Анжела ВРЫНЧЯНУ-БЕНЕШ
Константин СПЫНУ
Петру ЯРОВОЙ
Виктор ПЫНТЯ
Original Assignee
Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова filed Critical Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority to MDS20100040A priority Critical patent/MD223Z/en
Publication of MD223Y publication Critical patent/MD223Y/en
Publication of MD223Z publication Critical patent/MD223Z/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, in particular to infectious diseases and can be used for the prophylaxis of viral hepatitis B.According to the invention, the method for revaccination of children against viral hepatitis B consists in that beginning with the age of one year it is determined the annual level of anti-HBs and, if the level of anti-HBs is from 10 up to 150 mIU / ml is injected a booster dose of vaccine against viral hepatitis B, and if the level of anti-HBs is below 10 mIU / ml is injected an additional course of 3 or 4 doses of vaccine against viral hepatitis B.
MDS20100040A 2010-03-05 2010-03-05 Method for revaccination of children against viral hepatitis B MD223Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (en) 2010-03-05 2010-03-05 Method for revaccination of children against viral hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (en) 2010-03-05 2010-03-05 Method for revaccination of children against viral hepatitis B

Publications (2)

Publication Number Publication Date
MD223Y MD223Y (en) 2010-06-30
MD223Z true MD223Z (en) 2011-02-28

Family

ID=45815075

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100040A MD223Z (en) 2010-03-05 2010-03-05 Method for revaccination of children against viral hepatitis B

Country Status (1)

Country Link
MD (1) MD223Z (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis
  • 2010

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Engerix B. Instrucţiune de utilizare a vaccinului contra hepatitei virale B. Smith Kline Beecham Biologicals S.A., *
Rue de 1’ Institut 89, 1330 Rixensart, Belgium, 2002 *
WHO. Hepatitis B vaccine. Weekly epidemiological record, no. 28, 2004, p. 79, 253-264,<URL: http://www.who.int/wer/en/ > găsit 2010.04.26 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers

Also Published As

Publication number Publication date
MD223Y (en) 2010-06-30

Similar Documents

Publication Publication Date Title
Huo et al. The effect of vaccines on backward bifurcation in a fractional order HIV model
MD20140058A2 (en) Compositions and methods for treating hepatitis C virus
BR112018009009A8 (en) combined therapy of an hbv capsid formation inhibitor and an interferon
CY1117819T1 (en) Immunization of large mammals with low doses of RNA
UA117246C2 (en) SULFAMOILPYROLAMID DERIVATIVES AND THEIR APPLICATIONS AS A MEDICAMENT FOR THE TREATMENT OF HEPATITIS IN
BR112019004560A2 (en) combination treatment with tlr7 agonist and a hbv capsid formation inhibitor
IN2015DN01087A (en)
PH12014500911A1 (en) Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
PH12020500445A1 (en) Combination therapies of hepatitis b virus (hbv)-infected individuals using parapoxvirus ovis (ppvo) and at least one further antiviral drug
MY178496A (en) Antibody composition for prevention or treatment of mutant hepatitis b virus infection
EA201290556A1 (en) ORAL MEDICAL FORM, INCLUDING ENTEKAVIR
NZ714347A (en) Method of treating intracellular infection
MD223Z (en) Method for revaccination of children against viral hepatitis B
PH12017500617B1 (en) Dosage regimen for pegylated interferon
MY202118A (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus
Yang et al. The distribution and clinical sense of spontaneous YMDD mutation in 1444 patients chronic infected by HBV
UA59663U (en) method for prevention of acute respiratory viral infections in children of primary school age during the seasonal increase in respiratory infections
RU2005139920A (en) METHOD FOR SPECIFIC PREVENTION OF VIRAL HEPATITIS B IN ADULTS, PATIENTS WITH ACUTE Leukemia
Santoli VFC Resolution Update: Hepatitis B Vaccine [2016-10]
UA103870C2 (en) Method for detection of therapeutic tolerance of neuromodulator of natural origin xygerm-1 while correcting experimental fixated behavior syndrome
QIU et al. Factors related to clinical relapse in patients with chronic hepatitis B after withdrawal of nucleos (t) ide analogues
Kumar A new frontier in mindfulness-based therapies.
UA87210U (en) Method for treating infectious mononucleosis associated with epstein-barr virus in children with cholestasis syndrome
You et al. Monotherapy with Clevudine and Sequential Therapy with Clevudine and Pegylated Interferon in HBeAg Positive Chronic Hepatitis B Patients with High Viral Load
Kim et al. Anti-viral treatment in patients with immune tolerant-phase chronic hepatitis B may be cost-effective

Legal Events

Date Code Title Description
MK4Y Short term patent expired